Alliance for Clinical Trials in Oncology
- Country
- 🇺🇸United States
- Ownership
- Private
- Established
- 2011-01-01
- Employees
- 251
- Market Cap
- -
Citalopram in Treating Postmenopausal Women With Hot Flashes
- Conditions
- Psychosocial Effects of Cancer and Its TreatmentHot FlashesBreast Cancer
- Interventions
- Other: placebo
- First Posted Date
- 2006-08-15
- Last Posted Date
- 2016-12-13
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 254
- Registration Number
- NCT00363909
- Locations
- 🇺🇸
BroMenn Regional Medical Center, Normal, Illinois, United States
🇺🇸Rush-Copley Cancer Care Center, Aurora, Illinois, United States
🇺🇸Proctor Hospital, Peoria, Illinois, United States
Pilocarpine in Treating Vaginal Dryness in Patients With Breast Cancer
- Conditions
- Breast CancerVaginal Dryness
- Interventions
- Other: placebo
- First Posted Date
- 2006-06-23
- Last Posted Date
- 2016-08-12
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 201
- Registration Number
- NCT00343382
- Locations
- 🇺🇸
Galesburg Cottage Hospital, Galesburg, Illinois, United States
🇺🇸Mason District Hospital, Havana, Illinois, United States
🇺🇸McDonough District Hospital, Macomb, Illinois, United States
Gemcitabine and Carboplatin With or Without AZD2171 as First-Line Therapy in Treating Patients With Stage IIIB or Stage IV Non-Small Cell Lung Cancer
- Conditions
- Lung Cancer
- Interventions
- First Posted Date
- 2006-05-17
- Last Posted Date
- 2017-03-21
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 101
- Registration Number
- NCT00326599
- Locations
- 🇺🇸
Memorial Hospital, Carthage, Illinois, United States
🇺🇸McDonough District Hospital, Macomb, Illinois, United States
🇺🇸Holland Community Hospital, Holland, Michigan, United States
Calcium Gluconate and Magnesium Sulfate in Preventing Neurotoxicity Caused By Oxaliplatin in Patients Receiving Combination Chemotherapy for Stage II, Stage III, or Stage IV Colorectal Cancer That Has Been Completely Removed By Surgery
- Conditions
- Colorectal CancerNeurotoxicity
- Interventions
- First Posted Date
- 2006-04-21
- Last Posted Date
- 2016-08-11
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 104
- Registration Number
- NCT00316914
- Locations
- 🇺🇸
Medical Oncology and Hematology Associates at John Stoddard Cancer Center, Des Moines, Iowa, United States
🇺🇸Mercy Cancer Center at Mercy Medical Center - Des Moines, Des Moines, Iowa, United States
🇺🇸Avera Cancer Institute, Sioux Falls, South Dakota, United States
Cisplatin, Irinotecan, and Radiation Therapy in Treating Patients With Esophageal Cancer or Gastroesophageal Junction Cancer That Can Be Removed By Surgery
- Conditions
- Esophageal Cancer
- Interventions
- Procedure: therapeutic conventional surgeryRadiation: radiation therapy
- First Posted Date
- 2006-04-21
- Last Posted Date
- 2018-05-08
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 82
- Registration Number
- NCT00316862
- Locations
- 🇺🇸
Mountainview Medical, Berlin, Vermont, United States
🇺🇸Memorial Hospital of South Bend, South Bend, Indiana, United States
🇺🇸Michiana Hematology-Oncology, PC - South Bend, South Bend, Indiana, United States
Breast Density, Hormone Levels, and Anticancer Drug Levels in Women With Invasive Breast Cancer Who Are Receiving Exemestane or Anastrozole
- Conditions
- Breast Cancer
- Interventions
- Procedure: mammography
- First Posted Date
- 2006-04-21
- Last Posted Date
- 2019-01-24
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 554
- Registration Number
- NCT00316836
- Locations
- 🇺🇸
Hembree Mercy Cancer Center at St. Edward Mercy Medical Center, Fort Smith, Arkansas, United States
🇺🇸Riverside Methodist Hospital Cancer Care, Columbus, Ohio, United States
🇺🇸CCOP - Columbus, Columbus, Ohio, United States
Liposomal SN-38 in Treating Patients With Metastatic Colorectal Cancer
- First Posted Date
- 2006-04-06
- Last Posted Date
- 2016-06-29
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 30
- Registration Number
- NCT00311610
- Locations
- 🇺🇸
Tunnell Cancer Center at Beebe Medical Center, Lewes, Delaware, United States
🇺🇸Kaiser Permanente Medical Office -Vandever Medical Office, San Diego, California, United States
🇺🇸Union Hospital Cancer Program at Union Hospital, Elkton MD, Maryland, United States
Bortezomib After Combination Chemotherapy, Rituximab, and an Autologous Stem Cell Transplant in Treating Patients With Mantle Cell Lymphoma
- First Posted Date
- 2006-04-03
- Last Posted Date
- 2021-08-18
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 151
- Registration Number
- NCT00310037
- Locations
- 🇺🇸
Graham Hospital, Canton, Illinois, United States
🇺🇸Illinois CancerCare - Eureka, Eureka, Illinois, United States
🇺🇸Illinois CancerCare - Canton, Canton, Illinois, United States
Monoclonal Antibody Therapy and Combination Chemotherapy in Treating Patients With Stage II, Stage III, or Stage IV Diffuse Large B-Cell Lymphoma
- Conditions
- Lymphoma
- Interventions
- Biological: epratuzumabBiological: rituximab
- First Posted Date
- 2006-03-13
- Last Posted Date
- 2019-10-09
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 107
- Registration Number
- NCT00301821
- Locations
- 🇺🇸
Mason District Hospital, Havana, Illinois, United States
🇺🇸Perry Memorial Hospital, Princeton, Illinois, United States
🇺🇸Carle Cancer Center at Carle Foundation Hospital, Urbana, Illinois, United States
Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer
- Conditions
- Breast CancerDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
- Interventions
- Dietary Supplement: pyridoxine hydrochlorideDrug: urea/lactic acid-based topical creamOther: placebo
- First Posted Date
- 2006-02-24
- Last Posted Date
- 2017-03-16
- Lead Sponsor
- Alliance for Clinical Trials in Oncology
- Target Recruit Count
- 137
- Registration Number
- NCT00296036
- Locations
- 🇺🇸
Fredericksburg Oncology, Incorporated, Fredericksburg, Virginia, United States
🇺🇸Mayo Clinic Scottsdale, Scottsdale, Arizona, United States
🇺🇸Galesburg Clinic, PC, Galesburg, Illinois, United States